Skip to main content

Advertisement

Log in

Myocardial functional abnormalities and serum N-terminal pro-brain natriuretic peptide in type II diabetes mellitus patients with cardiovascular autonomic neuropathy

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

The aim was to investigate ventricular myocardial functions in patients with type II diabetes mellitus (DM) with cardiovascular autonomic neuropathy (CAN) in correlation with serum N-terminal pro-brain natriuretic peptide (NT-pro-BNP). We studied 56 patients with type II DM of >5 years’ duration. Thirty healthy subjects matched for age and sex served as control group. The patients with type II DM were divided into two groups according to the outcome of the autonomic nerve function tests as those with CAN (DM + CAN) and without CAN (DM). Echocardiographic studies were performed to assess ventricular functions. NT-pro-BNP levels were measured in all patients. Subclinical left ventricular diastolic dysfunction was not different between diabetic patients with CAN (84 %) and those without CAN (74.2 %); all of them were classified as impaired relaxation pattern (p > 0.05). Subclinical right ventricular diastolic dysfunction was not also different between diabetic patients with CAN (48 %) and those without CAN (32.3 %) (p > 0.05). The NT-pro-BNP levels were not different between patient groups and not significantly increased in patients with diastolic dysfunction. Multivariate logistic regression analysis demonstrated that only diabetes mellitus was associated with diastolic dysfunction (OR 5.8, 95 % CI 1.7–19.2, p = 0.004). NT-pro-BNP is not significantly elevated in diabetic patients with subclinical mild diastolic dysfunction which is not related to CAN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ledet T, Neubauer B, Christensen NJ, Lundbaek K. Diabetic cardiomyopathy. Diabetologia. 1979;16:207–9.

    Article  CAS  PubMed  Google Scholar 

  2. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25:543–67.

    Article  CAS  PubMed  Google Scholar 

  3. Tang WH, Young JB. Cardiomyopathy and heart failure in diabetes. Endocrinol Metab Clin N Am. 2001;30:1031–46.

    Article  CAS  Google Scholar 

  4. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;15:17–39.

    Article  Google Scholar 

  5. Debono M, Cachia E. The impact of cardiovascular autonomic neuropathy in diabetes: is it associated with left ventricular dysfunction? Auton Neurosci. 2007;132:1–7.

    Article  PubMed  Google Scholar 

  6. Struthers AD, Morris AD. Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet. 2002;359:1430–12.

    Article  PubMed  Google Scholar 

  7. Beer S, Golay S, Bardy D, Feihl F, Gaillard RC, Bachmann C, et al. Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications. Diabetes Metab. 2005;31:567–73.

    Article  CAS  PubMed  Google Scholar 

  8. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (2003). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S5-S20.

  9. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95–108.

    CAS  PubMed  Google Scholar 

  10. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165–93.

    Article  PubMed  Google Scholar 

  11. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713 .quiz 786-8

    Article  PubMed  Google Scholar 

  12. Chenevier-Gobeaux C, Claessens YE, Voyer S, Desmoulins D, Ekindjian OG. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the emergency department: comparison with brain natriuretic peptide (BNP). Clin Chim Acta. 2005;361:167–75.

    Article  CAS  PubMed  Google Scholar 

  13. Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004;93:870–5.

    Article  PubMed  Google Scholar 

  14. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48:1548–51.

    Article  PubMed  Google Scholar 

  15. From AM, Scott CG, Chen HH. Changes in diastolic dysfunction in diabetes mellitus over time. Am J Cardiol. 2009;103:1463–6.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kiencke S, Handschin R, von Dahlen R, Muser J, Brunner-Larocca HP, Schumann J, et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail. 2010;12:951–7.

    Article  PubMed  Google Scholar 

  17. Karamitsos TD, Karvounis HI, Dalamanga EG, Papadopoulos CE, Didangellos TP, Karamitsos DT, et al. Early diastolic impairment of diabetic heart: the significance of right ventricle. Int J Cardiol. 2007;114:218–23.

    Article  PubMed  Google Scholar 

  18. Kosmala W, Colonna P, Przewlocka-Kosmala M, Mazurek W. Right ventricular dysfunction in asymptomatic diabetic patients. Diabetes Care. 2004;27:2736–8.

    Article  PubMed  Google Scholar 

  19. Regan TJ, Lyons MM. Diabetic cardiomyopathy. Circulation. 1991;83:1830.

    CAS  PubMed  Google Scholar 

  20. Fang ZY, Schull-Meade R, Downey M, Prins J, Marwick TH. Determinants of subclinical diabetic heart disease. Diabetologia. 2005;48:394–402.

    Article  CAS  PubMed  Google Scholar 

  21. Kosmala W, Kucharski W, Przewlocka-Kosmala M, Mazurek W. Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol. 2004;94:395–9.

    Article  PubMed  Google Scholar 

  22. Didangelos TP, Arsos G, Karamitsos T, Iliadis F, Papageorgiou A, Moralidis E, et al. Left ventricular systolic and diastolic function in normotensive type 2 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study. Angiology. 2014;65:877–82.

    Article  PubMed  Google Scholar 

  23. Aydin Kaderli A, Güllülü S, Ozdemir B, Sentürk T, Aydinlar A. The relationship between cardiac autonomic neuropathy and Tei index in patients with type II diabetes mellitus. Acta Cardiol. 2008;63:629–33.

    Article  PubMed  Google Scholar 

  24. Vanninen E, Musconen J, Vainio P, Länsimies E, Uusitupa M. Left ventricular function and dimensions in newly diagnosed non-insulindependent diabetes meilitus. Am J Cardiol. 1992;70:371–8.

    Article  CAS  PubMed  Google Scholar 

  25. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Preclinical diabetic cardiomyopathy: Relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism. 2003;52:1056–61.

    Article  CAS  PubMed  Google Scholar 

  26. Sacre JW, Franjic B, Jellis CL, Jenkins C, Coombes JS, Marwick TH. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging. 2010;3:1207–15.

    Article  PubMed  Google Scholar 

  27. Karamitsos TD, Karvounis HI, Didangelos T, Parcharidis GE, Karamitsos DT. Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients: a tissue Doppler echocardiographic study. Diabetes Care. 2008;31:325–7.

    Article  PubMed  Google Scholar 

  28. Irace L, Iarussi D, Guadagno I, Tedesco MA, Perna B, Ratti G, et al. Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus. Acta Diabetol. 1996;33:269–73.

    Article  CAS  PubMed  Google Scholar 

  29. Romanens M, Fankhauser S, Saner B, Michaud L, Saner H. No evidence for systolic or diastolic left ventricular dysfunction at rest in selected patients with long-term type I diabetes mellitus. Eur J Heart Fail. 1999;1:169–75.

    Article  CAS  PubMed  Google Scholar 

  30. Goldweit R, Borer J, Jovanovic LG, Drexler AJ, Hochreiter CA, Devereux RB, et al. Relation of hemoglobin A1 and blood glucose to cardiac function in diabetes mellitus. Am J Cardiol. 1985;56:642–6.

    Article  CAS  PubMed  Google Scholar 

  31. DeMaria AN, Wisenbaugh TW, Smith MD, Harrison MR, Berk MR. Doppler echocardiographic evaluation of diastolic function. Circulation. 1991;84(3 Suppl):I288–95.

    CAS  PubMed  Google Scholar 

  32. Magnusson M, Jovinge S, Shahgaldi K, Israelsson B, Groop L, Melander O. Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc Diabetol. 2010;9:2.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Valle R, Bagolin E, Canali C, Giovinazzo P, Barro S, Aspromonte N, et al. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr. 2006;7:40–4.

    Article  CAS  PubMed  Google Scholar 

  34. Dencker M, Stagmo M, Dorkhan M. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes. Vasc Health Risk Manag. 2010;6:373–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Albertini JP, Cohen R, Valensi P, Sachs RN, Charniot JC. B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients. Diabetes Metab. 2008;34:355–62.

    Article  CAS  PubMed  Google Scholar 

  36. Çiftel S, Içağasıoğlu S, Yıldız G, Tekin G, Aydin H. Association of left ventricular diastolic dysfunction with elevated NT-proBNP in type 2 diabetes mellitus patients with preserved ejection fraction: the supplemantary role of tissue doppler imaging parameters and NT-proBNP levels. Diabetes Res Clin Pract. 2012;96:179–86.

    Article  PubMed  Google Scholar 

  37. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett Jr JC. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction. A community-based study. Circulation. 2004;109:3176–81.

  38. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH. Screening for heart disease in diabetic subjects. Am Heart J. 2005;149:349–54.

    Article  PubMed  Google Scholar 

  39. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002;105:595–601.

    Article  CAS  PubMed  Google Scholar 

  40. Ejaz A, LoGerfo FW, Pradhan L. Diabetic neuropathy and heart failure: role of neuropeptides. Expert Rev Mol Med. 2011;3:e26.

    Article  Google Scholar 

  41. Yufu K, Takahashi N, Nakagawa M, Hara M, Saikawa T, Yoshimatsu H. Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients. Diabetes Res Clin Pract. 2006;72:12–9.

    Article  CAS  PubMed  Google Scholar 

  42. Bayerle-Eder M, Zangeneh M, Kreiner G, Raffesberg W, Nowotny P, Vierhapper H, et al. ANP but not BNP reflects early left diastolic dysfunction in type 1 diabetics with myocardial dysinnervation. Horm Metab Res. 2003;35:301–7.

    Article  CAS  PubMed  Google Scholar 

  43. Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab. 2011;96:3242–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ertuğrul Zencirci.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zencirci, E., Yeşilaltay, A., Yağız, V. et al. Myocardial functional abnormalities and serum N-terminal pro-brain natriuretic peptide in type II diabetes mellitus patients with cardiovascular autonomic neuropathy. Int J Diabetes Dev Ctries 37, 272–279 (2017). https://doi.org/10.1007/s13410-016-0484-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-016-0484-7

Keywords

Navigation